Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting

To estimate real-world healthcare costs, resource utilization, and treatment patterns among metastatic melanoma (MM) patients who received a therapy recommended in current treatment guidelines during 2011 and 2012, following approval in the US of novel therapies (ipilimumab and vemurafenib). Adminis...

Full description

Saved in:

Bibliographic Details
Published in:	Current medical research and opinion Vol. 31; no. 8; pp. 1561 - 1572
Main Authors:	Toy, Edmond L., Vekeman, Francis, Lewis, Michael C., Oglesby, Alan K., Duh, Mei Sheng
Format:	Journal Article
Language:	English
Published:	England Informa Healthcare 03.08.2015
Subjects:	Adult Aged Antibodies, Monoclonal - therapeutic use Cohort Studies Female Health Care Costs Health Resources - utilization Healthcare costs Humans Ipilimumab Male Melanoma - secondary Melanoma - therapy Metastatic melanoma Middle Aged Resource utilization Retrospective Studies Treatment patterns Healthcare costs Metastatic melanoma Resource utilization Treatment patterns
ISSN:	0300-7995, 1473-4877
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!